Minghui Zhang
NO.1 Jianshe Road
Zhengzhou, 450052, China
Zhengzhou, 450052, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
4-1BB stimulation with concomitant inactivation of adenosine A2B receptors enhances CD8+ T cell antitumor response.
Journal: The Journal of clinical investigation
Published: January 03, 2025
Retraction Note: MicroRNA-338-3p suppresses ovarian cancer cells growth and metastasis: implication of Wnt/catenin beta and MEK/ ERK signaling pathways.
Journal: Journal of experimental & clinical cancer research : CR
Published: February 14, 2024
Targeting of KDM5A by miR-421 in Human Ovarian Cancer Suppresses the Progression of Ovarian Cancer Cells.
Journal: OncoTargets and therapy
Published: July 15, 2020
MicroRNA-338-3p suppresses ovarian cancer cells growth and metastasis: implication of Wnt/catenin beta and MEK/ERK signaling pathways.
Journal: Journal of experimental & clinical cancer research : CR
Published: September 19, 2019
Erratum: WEE1 inhibition by MK1775 as a single-agent therapy inhibits ovarian cancer viability.
Journal: Oncology letters
Published: August 01, 2018
Type 2 Innate Lymphoid Cells Impede IL-33-Mediated Tumor Suppression.
Journal: Journal of immunology (Baltimore, Md. : 1950)
Published: February 05, 2018
Application of chimeric antigen receptor-engineered T cells in ovarian cancer therapy.
Journal: Immunotherapy
Published: September 08, 2017
The aberrant upstream pathway regulations of CDK1 protein were implicated in the proliferation and apoptosis of ovarian cancer cells.
Journal: Journal of ovarian research
Published: May 30, 2017
Exogenous IL-33 overcomes T cell tolerance in murine acute myeloid leukemia.
Journal: Oncotarget
Published: February 11, 2016
WEE1 inhibition by MK1775 as a single-agent therapy inhibits ovarian cancer viability.
Journal: Oncology letters
Published: November 14, 2015
Last Updated: 09/26/2026